Azacitidine
- Product NDC
- 67457-254
- 11-digit product format
- 674570254
- Labeler code
- 67457
- Product ID
- 67457-254_7739eb5a-5c1f-4527-9e0a-ca934a461749
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- azacitidine
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Mylan Institutional LLC
- Application
- ANDA204949
- Marketing category
- ANDA
- Marketing start
- 2016-05-23
- Marketing end
- 0000-00-00
- Substance
- AZACITIDINE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67457-254-30 | 67457025430 | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (67457-254-30) | 2016-05-23 | 0000-00-00 | No | No | Current |